TARGETING SCIENCEFreezing Funding Halts Medical, Engineering, and Scientific Research
The Trump administration’s decision to freeze more than $2 billion in long-term research grants to Harvard has put a halt to work across a wide range of medical, engineering, and scientific fields. The projects focus on issues from TB and chemotherapy to prolonged space travel and pandemic preparedness.
The Trump administration’s decision to freeze more than $2 billion in long-term research grants to Harvard has put a halt to work across a wide range of medical, engineering, and scientific fields. The action came in response to the rejection of White House demands for changes that the University argues infringes on its independence and constitutional rights and exceeds the administration’s lawful authority.
The NIH had earlier halted an estimated $110 million in grants to Harvard and its associated hospitals since late February.
We interviewed some of the researchers whose projects have been halted or face an uncertain future.
Sarah Fortune, John LaPorte Given Professor of Immunology and Infectious Diseases, and chair of the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health
Research interrupted: A $60 million seven-year, multi-institutional consortium to study how the immune system controls tuberculosis.
“About a third of the world is thought to be infected with TB and carry TB, and most of those people will not get sick. But every year, 10 million people get sick, and 1 million people die, which makes TB the world’s leading infectious cause of death. We’re trying to understand the difference between protective and failed immunity to TB to better identify people with TB and then prevent TB, ideally with an effective vaccine.
“This consortium was conceived of at the National Institutes of Health as their moonshot effort to move the needle on TB. The goal was to bring together the very best researchers from around the country and around the world to bring the very best cutting-edge technology, the very best science to understand TB immunity. And if it stops, the whole thing is gone.
“I’ve been building this consortium since about 2014. For me, this is over a decade of work. Scientific knowledge, scientific expertise is a craft. And if you blow it up, you can’t just rehire people and recreate it and then start again. It’s gone.”
[Open Philanthropy, a California-based philanthropic group, has authorized a $500,000 grant to allow researchers at the University of Pittsburgh School of Medicine to complete an ongoing tuberculosis vaccine study, The Boston Globe reported Monday. That study is a single piece of the broader project Fortune is working on as a principal investigator.]
